Advertisement

Topics

Europe Tumor Markers Testing Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities [Report Updated: 22062017] Prices from USD $19700

07:46 EDT 3 Jul 2017 | BioPortfolio Reports

Complete report $19,700.DataPack test volumes, sales forecasts, supplier shares $12,800.

Summary

This comprehensive fivecountrynbsp;report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the nextnbsp;five years. The report examines trends in major European countries France, Germany, Italy, Spain, UK; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
nbsp;
Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Cancer Diagnostic Tests

ACTH, AFP, Beta2 Microglobulin, CA 153/27.29, CA 199, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, ColonSpecific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, NeuronSpecific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Geographic Coverage

France, Germany, Italy, Spain, UK

Market Segmentation Analysis

Sales and market shares of major suppliers,
by individual cancer diagnostic test and country.

Fiveyear test volume and sales forecasts
for major cancer diagnostic tests
by country and market segment, including:

Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices

Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
by country.

Cancer statistics, etiology and recent developments in
five major European countries.

Current and Emerging Products

Review of over 200 current and emerging cancer diagnostic tests,
including:

Biochemical Markers
Oncogenes
Growth Factors
Hormones
Colony Stimulating Factors
Lymphokines
Immunohistochemical Stains, and others.

Analysis of major immunoassay analyzers used for
cancer diagnostic testing, including their operating characteristics,
features and selling prices.

Technology Review

Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and other technologies
and their potential applications for cancer diagnostic testing.

Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.

Extensive listings of over 500 companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.

Competitive Assessments

Strategic assessments ofnbsp;major suppliers
and startup firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in Ramp;D.

Business Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially
significant market appeal during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Contains 820 pages and 320 tables

nbsp;

Original Article: Europe Tumor Markers Testing Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities [Report Updated: 22062017] Prices from USD $19700

NEXT ARTICLE

More From BioPortfolio on "Europe Tumor Markers Testing Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities [Report Updated: 22062017] Prices from USD $19700"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...